iSpecimen
ISPC
12 hedge funds and large institutions have $1.98M invested in iSpecimen in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
20% more funds holding
Funds holding: 10 → 12 (+2)
9.76% less ownership
Funds ownership: 13.29% → 3.53% (-9.8%)
79% less capital invested
Capital invested by funds: $9.21M → $1.98M (-$7.23M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$313K |
| 2 |
TA
Teton Advisors
Rye,
New York
|
+$195K |
| 3 |
GC
Grimes & Company
Westborough,
Massachusetts
|
+$168K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$97.7K |
| 5 |
Jane Street
New York
|
+$50.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Empery Asset Management
New York
|
-$3.64M |
| 2 |
KC
Kepos Capital
New York
|
-$1.48M |
| 3 |
BL
Bleichroeder LP
New York
|
-$1.35M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$266K |
| 5 |
EGM
Engineers Gate Manager
New York
|
-$211K |
ISPC Hedge Fund Activity: Q1 2022 in Review
12 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q1 2022, worth a combined $1.98M — down 79% from $9.21M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ISPC positions and 5 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was BlackRock, adding an estimated $313K. The largest seller was Empery Asset Management, exiting entirely with an estimated $3.64M sold.
- 12 institutional investors held iSpecimen (ISPC) as of Q1 2022, up from 10 in Q4 2021.
- Funds reported $1.98M of iSpecimen stock for Q1 2022, down 79% quarter-over-quarter.
- 7 funds opened new iSpecimen positions in Q1 2022 and 5 closed out, a net change of +2 holders.
- The largest iSpecimen buyer in Q1 2022 was BlackRock, an estimated $313K added.
- The largest iSpecimen seller in Q1 2022 was Empery Asset Management, an estimated $3.64M sold.
Based on aggregated 13F filings for Q1 2022.